Literature DB >> 30429972

On the inhibition of capsaicin response in dorsal root ganglion neurons by nobilamide B and analogues: a structure-activity relationship study.

Oliver John V Belleza1, Jortan O Tun2, Gisela P Concepcion2, Aaron Joseph L Villaraza1.   

Abstract

Nobilamide B, a TRPV1 antagonist, and a series of Ala-substituted analogues were synthesized and their neuroactivity was assessed in a primary culture of dorsal root ganglion (DRG) neurons. Analogues 4, 6, and 7 showed comparable activity, affecting capsaicin response in neurons, in contrast to 2, 3, and 5 which showed minimal blocking. Compounds 2, 3, and 5 correspond to analogues in which d-Phe, d-Leu and d-allo-Thr have been substituted with Ala, respectively. The observed loss of bioactivity in these three analogues highlights the importance of d amino acids in the primary structure of nobilamide B.

Entities:  

Year:  2018        PMID: 30429972      PMCID: PMC6194998          DOI: 10.1039/c8md00304a

Source DB:  PubMed          Journal:  Medchemcomm        ISSN: 2040-2503            Impact factor:   3.597


  16 in total

Review 1.  Combinatorial alanine-scanning.

Authors:  K L Morrison; G A Weiss
Journal:  Curr Opin Chem Biol       Date:  2001-06       Impact factor: 8.822

2.  Functional profiling of neurons through cellular neuropharmacology.

Authors:  Russell W Teichert; Nathan J Smith; Shrinivasan Raghuraman; Doju Yoshikami; Alan R Light; Baldomero M Olivera
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-23       Impact factor: 11.205

Review 3.  International Union of Basic and Clinical Pharmacology. LXXVI. Current progress in the mammalian TRP ion channel family.

Authors:  Long-Jun Wu; Tara-Beth Sweet; David E Clapham
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

4.  Analysis of Endogenous D-Amino Acid-Containing Peptides in Metazoa.

Authors:  Lu Bai; Sarah Sheeley; Jonathan V Sweedler
Journal:  Bioanal Rev       Date:  2009-12

Review 5.  Modulation of the TRPV1 channel: current clinical trials and recent patents with focus on neurological conditions.

Authors:  Luciano De Petrocellis; Aniello S Moriello
Journal:  Recent Pat CNS Drug Discov       Date:  2013-12

6.  Identifying key amino acid residues that affect α-conotoxin AuIB inhibition of α3β4 nicotinic acetylcholine receptors.

Authors:  Anton A Grishin; Hartmut Cuny; Andrew Hung; Richard J Clark; Andreas Brust; Kalyana Akondi; Paul F Alewood; David J Craik; David J Adams
Journal:  J Biol Chem       Date:  2013-10-07       Impact factor: 5.157

7.  Synthesis and bioactivity of nobilamide B.

Authors:  M P V Jacinto; M S Flores; Z Lin; G P Concepcion; E W Schmidt; S Faulkner; A J L Villaraza
Journal:  RSC Adv       Date:  2014       Impact factor: 3.361

8.  Structure-activity relationship studies on the novel neuropeptide orphanin FQ.

Authors:  R K Reinscheid; A Ardati; F J Monsma; O Civelli
Journal:  J Biol Chem       Date:  1996-06-14       Impact factor: 5.157

9.  Structure of the analgesic mu-conotoxin KIIIA and effects on the structure and function of disulfide deletion.

Authors:  Keith K Khoo; Zhi-Ping Feng; Brian J Smith; Min-Min Zhang; Doju Yoshikami; Baldomero M Olivera; Grzegorz Bulaj; Raymond S Norton
Journal:  Biochemistry       Date:  2009-02-17       Impact factor: 3.162

Review 10.  The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept.

Authors:  Arpad Szallasi; Daniel N Cortright; Charles A Blum; Samer R Eid
Journal:  Nat Rev Drug Discov       Date:  2007-05       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.